1-2 of 2
Emilio Bombardieri, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High-Dose Myeloablative Zevalin Radioimmunotherapy with Tandem Stem-Cell Autografting Has Promising Activity, Minimal Toxicity and Full Feasibility in an Outpatient Setting.

Liliana Devizzi, MD, Ettore Seregni, MD, Anna Guidetti, MD, Chiara Forni, MD, Angela Coliva, MD, Michele Magni, MD, Massimo Di Nicola, MD, Carmelo Carlo-Stella, MD, Paola Matteucci, MD, Antonella De Pascale, MD, Claudia Erminero, MD, Marco Maccauro, MD, Carlo Chiesa, PhD, Emilio Bombardieri, MD, Pinuccia Valagussa, Alessandro M. Gianni, MD
Journal: Blood
Blood (2006) 108 (11): 3047.
https://doi.org/10.1182/blood.V108.11.3047.3047
Published: 2006
Journal Articles

High-Dose Myeloablative Zevalin Radioimmunotherapy with Tandem Stem-Cell Autografting Has Minimal Toxicity and Full Feasibility in an Outpatient Setting.

Liliana Devizzi, MD, Ettore Seregni, MD, Anna Guidetti, MD, Chiara Forni, MD, Angela Coliva, PhD, Michele Magni, MD, Massimo Di Nicola, MD, Carmelo Carlo-Stella, MD, Paola Matteucci, MD, Antonella De Pascale, MD, Claudia Erminero, MD, Marco Maccauro, MD, Carlo Chiesa, MD, Emilio Bombardieri, MD, Alessandro M. Gianni, MD
Journal: Blood
Blood (2005) 106 (11): 2737.
https://doi.org/10.1182/blood.V106.11.2737.2737
Published: 2005